A person-centred approach to
Improving uptake of
Fracture Prevention
drug treatments
The iFraP study is developing and testing a package of resources to support clinicians and patients make informed decisions about osteoporosis medicines to improve patient-centred care.
In the UK, three million people are estimated to have osteoporosis, contributing to over 500,000 broken bones (fractures resulting from low trauma) per year. Patients have told us that they require understandable information to make decisions about osteoporosis medicines, that are right for them. We have developed iFraP to help patients and health care professionals to make decisions together
We are currently recruiting patients to take part in the iFraP trial. To learn more about what is involved in the iFraP trial…
In the UK, three million people are estimated to have osteoporosis, contributing to over 500,000 broken bones (fractures resulting from low trauma) per year. Patients have told us that they require understandable information to make decisions about osteoporosis medicines, that are right for them. We have developed iFraP to help patients and health care professionals to make decisions together
We are currently recruiting patients to take part in the iFraP trial. To learn more about what is involved in the iFraP trial…
RT @LaurnaBullock: Fantastic to give an overview of the @iFraP_Study in-practice testing findings and the invaluable role of our PPIE membe… Read More
IFraP on tour! Great couple of days in Denmark @isdmsociety #isdm2022 Great to learn about exciting shared decision making initiatives across the globe @zpaskins @LaurnaBullock https://t.co/0vZZs6ZIwf Read More
We used a complex intervention approach to develop iFrap and a breaking bad news model SPIKES to develop training in SDM, also taking into account universal precautions for #healthliteracy our protocol paper #ISDM2022 https://t.co/GAT4ortC5G Read More
RT @zpaskins: @LaurnaBullock at #ISDM2022 presenting poster on @iFraP_Study prototype testing https://t.co/HGLZZSZNrn Read More
This study has been reviewed and given favourable opinion by East of Scotland Research Ethics Service (reference: 22/ES/0038).
